Detalles de la búsqueda
1.
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCE.
Transfusion;
64(2): 223-235, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38323704
2.
The effects of secondary iron overload and iron chelation on a radiation-induced acute myeloid leukemia mouse model.
BMC Cancer;
21(1): 509, 2021 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33957868
3.
Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
Br J Haematol;
191(3): 476-485, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449174
4.
How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry.
Eur J Haematol;
102(1): 36-52, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30242915
5.
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies.
Am J Hematol;
99(3): 473-476, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38126081
6.
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS-CAN analysis.
Br J Haematol;
179(1): 83-97, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28677895
7.
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry.
Ann Hematol;
96(12): 2025-2029, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28975386
8.
Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study.
Br J Haematol;
174(1): 88-101, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26991631
9.
TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients.
Proc Natl Acad Sci U S A;
110(40): 16127-32, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24043769
10.
Retrospective study of non-natural manners of death in Ontario: Effects of the COVID-19 pandemic and related public health measures.
Lancet Reg Health Am;
7: 100130, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34927128
11.
The Use of Cremation Data for Timely Mortality Surveillance During the COVID-19 Pandemic in Ontario, Canada: Validation Study.
JMIR Public Health Surveill;
8(2): e32426, 2022 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35038302
12.
Generation of high-titer viral preparations by concentration using successive rounds of ultracentrifugation.
J Transl Med;
9: 137, 2011 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-21849073
13.
Myelodysplastic syndrome.
CMAJ;
188(10): 751, 2016 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26728842
14.
Intracellular ROS profile in hematopoietic progenitors of MDS patients: association with blast count and iron overload.
Hematology;
26(1): 88-95, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34000978
15.
Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo.
J Exp Med;
195(11): 1387-95, 2002 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-12045237
16.
The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study.
Leuk Res;
76: 76-81, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30580105
17.
Iron overload in myelodysplastic syndromes: a Canadian consensus guideline.
Leuk Res;
32(9): 1338-53, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18405971
18.
An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis.
Exp Hematol;
59: 60-65, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29195897
19.
The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo.
Biomark Res;
6: 36, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30555701
20.
Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS.
Leuk Res;
74: 21-41, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30286330